134458-76-7 Usage
Uses
Used in Pharmaceutical Industry:
(2R,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-((2S)-3-(1H-imidazol-5-yl)-2-[(phenoxyacetyl)amino]propanoylamino)-2-(1-methylethyl)-N-(1S,2S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butylhexanamide (non-preferred name) is used as a potential therapeutic agent for various medical conditions due to its complex structure and the presence of multiple functional groups that can interact with biological targets.
Used in Chemical Research:
(2R,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-((2S)-3-(1H-imidazol-5-yl)-2-[(phenoxyacetyl)amino]propanoylamino)-2-(1-methylethyl)-N-(1S,2S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butylhexanamide (non-preferred name) is also used in chemical research as a model for studying the synthesis and reactivity of complex organic molecules, as well as for understanding the interactions between different functional groups within a single molecule.
Used in Material Science:
The unique structure of (2R,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-((2S)-3-(1H-imidazol-5-yl)-2-[(phenoxyacetyl)amino]propanoylamino)-2-(1-methylethyl)-N-(1S,2S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butylhexanamide (non-preferred name) may have potential applications in material science, particularly in the development of new materials with specific properties based on its molecular structure and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 134458-76-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,4,5 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 134458-76:
(8*1)+(7*3)+(6*4)+(5*4)+(4*5)+(3*8)+(2*7)+(1*6)=137
137 % 10 = 7
So 134458-76-7 is a valid CAS Registry Number.
134458-76-7Relevant academic research and scientific papers
Inhibitors of the Protease from Human Immunodeficiency Virus: Design and Modeling of a Compound Containing a Dihydroxyethylene Isostere Insert with High Binding Affinity and Effective Antiviral Activity
Thaisrivongs, Suvit,Tomasselli, Alfredo G.,Moon, Joseph B.,Hui, John,McQuade, Thomas J.,et al.
, p. 2344 - 2356 (2007/10/02)
The peptidomimetic template and the dihydroxyethylene isostere insert that were applied successfully to the design of renin inhibitors have been extended to the related protease from human immunodeficiency virus (HIV).The present report describes the stru
